Kyle Rasbach Lexeo Therapeutics, Inc. (LXEO) insider trading activity

LXEO Quotes by TradingView
Shares Held (Direct Ownership) 40.9K
n/a 3M change
n/a 12M change
Total Value Held N/A

Kyle Rasbach Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 17 2025
BUY
Grant, award, or other acquisition
-
40,875 Added 50.0%
40,875 Common Stock
KR

Kyle Rasbach

Chief Financial Officer
New York, NY

Track Institutional and Insider Activities on LXEO

Follow Lexeo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LXEO shares.

Notify only if

Insider Trading

Get notified when an Lexeo Therapeutics, Inc. insider buys or sells LXEO shares.

Notify only if

News

Receive news related to Lexeo Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LXEO